About 1 in 8 Americans uses GLP-1 drugs for diabetes, weight loss and other chronic conditions, including semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)
The first major step in MDL 3094 is the request for and production of millions of pages of documents by Mounjaro manufacturer Eli Lilly
A five-year remission period might be a reasonable threshold before considering MOTS-c, but this should be an individual decision made with oncologist input
Hattori Y, Nakagawa Y, Onishi H
ClinicalTrials.gov [online], [DOI] [PubMed] 120.Inanaga K, et al
Lastly, it would be beneficial to conduct research on the possible synergistic anti-inflammatory benefits of combination therapy (GLP-1 RAs with SGLT2 inhibitors, nonsteroidal MRA, or targeted anti-inflammatory drugs)